Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Teniposide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP2A known ✓ | P11388 | 4/20 | 0.48 |
| ▸ | TOP2B known ✓ | Q02880 | 4/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.48 |
| ▸ | GAA | P10253 | 4/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.48 |
| ▸ | USP2 | O75604 | 3/20 | 0.48 |
| ▸ | NCOA3 | Q9Y6Q9 | 2/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.48 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.48 |
| ▸ | TOP1 | P11387 | 10/20 | 0.40 |
| ▸ | MEN1 | O00255 | 5/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | CASP1 | P29466 | 2/20 | 0.40 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.40 |
| ▸ | CASP7 | P55210 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Teniposide SCHEMBL5969910 | 0.89 | SMN1; SMN2 (0.61) | SMN1; SMN2GAACYP3A4TOP2ATOP2B | |
| Teniposide SCHEMBL5324539 | 0.87 | SMN1; SMN2 (0.58) | SMN1; SMN2GAACYP3A4TOP2ATOP2B | |
| Teniposide SCHEMBL2872864 | 0.86 | SMN1; SMN2 (0.56) | SMN1; SMN2GAACYP3A4TOP2ATOP2B | |
| Etoposide SCHEMBL1276328 | 0.82 | SMN1; SMN2 (0.57) | SMN1; SMN2GAACYP3A4TOP2ATOP2B | |
| Teniposide SCHEMBL1276780 | 0.82 | GAA (0.66) | SMN1; SMN2GAACYP3A4TOP2ATOP2B | |
| Teniposide SCHEMBL4763786 | 0.79 | GAA (0.49) | SMN1; SMN2GAACYP3A4TOP2ATOP2B | |
| Teniposide SCHEMBL8350778 | 0.76 | GAA (0.53) | SMN1; SMN2GAACYP3A4TOP2ATOP2B | |
| Etoposide SCHEMBL14931202 | 0.75 | GAA (0.61) | SMN1; SMN2GAACYP3A4TOP2ATOP2B | |
| Etoposide SCHEMBL18921683 | 0.75 | GAA (0.61) | SMN1; SMN2GAACYP3A4TOP2ATOP2B | |
| Irinotecan SCHEMBL17102276 | 0.74 | GAA (0.54) | SMN1; SMN2GAACYP3A4TOP2ATOP2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107847572-A | Vaccine for treatment of cancer and prevention | 艾吉纳斯公司 | 2018-03-27 | — | — | CN | disclosed |